Personalised Prescribing – Using pharmacogenomics to improve patient outcomes, a report from the British Pharmacological Society and the Royal College of Physicians published 28 March 2022, calls for pharmacogenomic testing to be integrated fully, fairly and swiftly into the NHS.
Read the full report
Further reading
Read our new story about the launch of the report
Read the British Journal of Pharmacology's commentary on the report
Patient case studies
Peter Ley
Peter Ley is a colon cancer patient whose chemotherapy was adjusted after a pharmacogenomic test showed he had a deficiency of dihydropyrimidine dehydrogenase (DPD). Read Peter's story.
Jane Burns
Jane Burns, suffered a severe reaction to an epilepsy medication called carbamazenine, which caused her to lose 65% of the skin on her body. Pharmacogenomic testing could have prevented this. Read Jane's story.